Core Laboratories NV (CLB)
Profitability ratios
Return on sales
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|
| Gross profit margin | 11.34% | 99.29% | 99.27% | 99.26% |
| Operating profit margin | 11.25% | 11.40% | 10.66% | 11.37% |
| Pretax margin | 8.73% | 7.02% | 6.23% | 6.89% |
| Net profit margin | 6.03% | 5.07% | 4.70% | 7.52% |
Core Laboratories NV has showcased impressive levels of profitability, as evidenced by its consistently high gross profit margins ranging from 99.26% to 99.29% throughout the year. This indicates that the company effectively controls its production costs and generates strong profits from its core operations.
In terms of operating profit margin, Core Laboratories NV maintained a stable performance with margins fluctuating slightly between 10.66% and 11.40%. This metric reflects the company's ability to efficiently manage its operating expenses and generate profits from its core business activities.
Moreover, the pretax margin improved gradually from 6.23% in June 2024 to 8.73% in December 2024. This suggests that Core Laboratories NV effectively managed its non-operating expenses and taxes, resulting in higher profitability before taxes.
Lastly, the net profit margin, which represents the company's bottom-line profitability, ranged from 4.70% to 7.52% during the year. Although there was some variability, the margins remained relatively stable, indicating Core Laboratories NV's ability to translate its revenues into net profits efficiently.
Overall, Core Laboratories NV's profitability ratios reflect a strong financial performance, with consistently high gross profit margins and stable operating, pretax, and net profit margins throughout the year.
Return on investment
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | |
|---|---|---|---|---|
| Operating return on assets (Operating ROA) | 9.92% | 9.82% | 9.01% | 9.65% |
| Return on assets (ROA) | 5.32% | 4.36% | 3.97% | 6.38% |
| Return on total capital | 15.29% | 12.72% | 11.56% | 12.18% |
| Return on equity (ROE) | 12.46% | 10.45% | 9.87% | 16.16% |
Core Laboratories NV's profitability ratios show a stable performance over the quarters analyzed.
- The Operating return on assets (Operating ROA) ranged from 9.01% to 9.92%, indicating that the company generated approximately 9% to 10% in operating profits for every dollar of assets held during the period.
- Return on assets (ROA) varied from 3.97% to 6.38%, illustrating that the company generated between 4% and 6% in profits for every dollar of assets held.
- Return on total capital ranged from 11.56% to 15.29%, demonstrating that the company earned approximately 12% to 15% on its total invested capital.
- Return on equity (ROE) fluctuated from 9.87% to 16.16%, reflecting the company's ability to generate between 10% and 16% in profits for each dollar of shareholders' equity invested.
Overall, Core Laboratories NV's profitability ratios show a consistent performance, with some fluctuations but generally indicating the company's ability to generate profits from its assets, capital, and equity.